Autologous Platelet Rich Plasma (PRP) for the Treatment of Chronic Non-Healing Ulcers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

April 30, 2016

Study Completion Date

May 31, 2016

Conditions
Chronic Ulcer
Interventions
BIOLOGICAL

Autologous PRP Gel and PRP Injection

"Autologous PRP prepared using the Res-Q™ 60 PRP system from patient's whole blood, will be injected subcutaneously around the periphery of the wound/ulcer.~Based on the wound size and area, autologous platelet gel obtained by spraying simultaneously equal volumes of PRP and activator solution (thrombin with calcium chloride) will be applied topically over the ulcer or wound.~Single dose of PRP injections and application of PRP gel will be administered, only on the day of treatment."

Trial Locations (1)

110025

Fortis Escorts Heart Institute and Research Centre, Delhi

All Listed Sponsors
lead

TotipotentRX Cell Therapy Pvt. Ltd.

INDUSTRY

NCT03026855 - Autologous Platelet Rich Plasma (PRP) for the Treatment of Chronic Non-Healing Ulcers | Biotech Hunter | Biotech Hunter